COVID-19 : : Global Status.

• Author: Gideon Informatics, Inc.
• TeilnehmendeR: Berger, Stephen.; GIDEON science team, Gideon science.
• Place / Publishing House: Los Angeles : : Gideon Informatics, Incorporated,, 2023.; Ã2023.
• Year of Publication: 2023
• Edition: 1st ed.
• Language: English
• Physical Description: 1 online resource (951 pages)

Table of Contents

• Intro
• Copyright
• Introduction: The GIDEON e-book series
• Table of Contents
• COVID-19
• Epidemiology
• Agent
• Reservoir
• Vector
• Vehicle
• Incubation Period
• Diagnostic Tests
• Typical Adult Therapy
• Typical Pediatric Therapy
• Vaccines
• Clinical Hints
• Synonyms
• References
• Clinical
• References
• Distribution Map
• Images
• Global status
• References
• Afghanistan
• References
• Albania
• References
• Algeria
• References
• American Samoa
• References
• Andorra
• References
• Angola
• References
• Anguilla
• References
• Antigua and Barbuda
• References
• The Antilles (miscellaneous)
• References
• Argentina
• References
• Armenia
• References
• Aruba
• References
• Australia
• References
• Austria
• References
• Azerbaijan
• References
• The Azores
• References
• The Bahamas
• References
• Bahrain
• References
• Bangladesh
• References
• Barbados
• References
• Belarus
• References
• Belgium
• References
• Belize
• References
• Benin
• References
• Bermuda
• References
• Bhutan
• References
• Bolivia
• References
• Bosnia and Herzegovina
• References
• Botswana
• References
• Brazil
• References
• The British Virgin Islands
• References
• Brunei
• References
• Bulgaria
• References
• Burkina Faso
• References
• Burundi
• References
• Cambodia
• References
• Cameroon
• References
• Canada
• References
• The Canary Islands
• References
• Cape Verde
• References
• The Cayman Islands
• References
• Central African Republic
• References
• Chad
• References
• Chile
• References
• China
• References
• Colombia
• References
• The Comoros and Mayotte
• References
• Congo
• References
• The Cook Islands
• References
• Costa Rica
• References
• Croatia
• References
• Cuba
• References
• Cyprus
• References.
• The Czech Republic
• References
• The Democratic Republic of Congo
• References
• Denmark
• References
• Djibouti
• References
• Dominica
• References
• The Dominican Republic
• References
• East Timor
• References
• Ecuador
• References
• Egypt
• References
• El Salvador
• References
• Equatorial Guinea
• References
• Eritrea
• References
• Estonia
• References
• Eswatini
• References
• Ethiopia
• References
• The Falkland Islands
• References
• Fiji
• References
• Finland
• References
• France
• References
• French Guiana
• References
• French Polynesia
• References
• Gabon
• References
• Gambia
• References
• Georgia
• References
• Germany
• References
• Ghana
• References
• Gibraltar
• References
• Greece
• References
• Greenland
• References
• Grenada
• References
• Guadeloupe
• References
• Guam
• References
• Guatemala
• References
• Guinea
• References
• Guinea Bissau
• References
• Guyana
• References
• Haiti
• References
• Honduras
• References
• Hong Kong
• References
• Hungary
• References
• Iceland
• References
• India
• References
• Indonesia
• References
• Iran
• References
• Iraq
• References
• Ireland
• References
• Israel
• References
• Italy
• References
• Ivory Coast
• References
• Jamaica
• References
• Japan
• References
• Jordan
• References
• Kazakhstan
• References
• Kenya
• References
• Kiribati
• References
• Kosovo
• References
• Kuwait
• References
• Kyrgyzstan
• References
• Laos
• References
• Latvia
• References
• Lebanon
• References
• Lesotho
• References
• Liberia
• References
• Libya
• References
• Liechtenstein
• References
• Lithuania
• References
• Luxembourg
• References
• Macao
• References
• Madagascar
• References
• Malawi
• References
• Malaysia
• References.
• The Maldives
• References
• Mali
• References
• Malta
• References
• The Marshall Islands
• References
• Martinique
• References
• Mauritania
• References
• Mauritius
• References
• Mexico
• References
• Micronesia
• References
• Moldova
• References
• Monaco
• References
• Mongolia
• References
• Montenegro
• References
• Montserrat
• References
• Morocco
• References
• Mozambique
• References
• Myanmar
• References
• Namibia
• References
• Nauru
• Nepal
• References
• The Netherlands
• References
• New Caledonia
• References
• New Zealand
• References
• Nicaragua
• References
• Niger
• References
• Nigeria
• References
• Niue
• References
• North Macedonia
• References
• Northern Ireland
• References
• The Northern Marianas
• References
• Norway
• References
• Oman
• References
• Pakistan
• References
• Palau
• References
• Panama
• References
• Papua New Guinea
• References
• Paraguay
• References
• North Korea
• References
• Peru
• References
• The Philippines
• References
• Pitcairn Island
• Poland
• References
• Portugal
• References
• Puerto Rico
• References
• Qatar
• References
• South Korea
• References
• Reunion
• References
• Romania
• References
• The Russian Federation
• References
• Rwanda
• References
• Samoa
• References
• San Marino
• References
• Sao Tome and Principe
• References
• Saudi Arabia
• References
• Scotland
• References
• Senegal
• References
• Serbia
• References
• The Seychelles
• References
• Sierra Leone
• References
• Singapore
• References
• Slovakia
• References
• Slovenia
• References
• The Solomon Islands
• References
• Somalia
• References
• South Africa
• References
• South Sudan
• References
• Spain
• References
• Sri Lanka
• References
• St. Helena
• References.
• Saint Kitts and Nevis
• References
• Saint Lucia
• References
• Saint Vincent and The Grenadines
• References
• Sudan
• References
• Suriname
• References
• Sweden
• References
• Switzerland
• References
• Syria
• References
• Taiwan
• References
• Tajikistan
• References
• Tanzania
• References
• Thailand
• References
• Togo
• References
• Tokelau
• Tonga
• References
• Trinidad and Tobago
• References
• Tunisia
• References
• Turkey
• References
• Turkmenistan
• References
• The Turks and Caicos Islands
• References
• Tuvalu
• Uganda
• References
• Ukraine
• References
• The United Arab Emirates
• References
• The United Kingdom
• References
• The United States
• References
• Uruguay
• References
• Uzbekistan
• References
• Vanuatu
• References
• Venezuela
• References
• Vietnam
• References
• The U.S. Virgin Islands
• References
• Wallis and Futuna Islands
• References
• Western Sahara
• References
• Yemen
• References
• Zambia
• References
• Zimbabwe
• References
• Vaccines &amp
• Immunoglobulins
• Bamlanivimab
• Mechanism of Action
• Typical Adult Dosage
• Typical Pediatric Dosage
• Subsequent booster
• Toxic Effects for Bamlanivimab (2 listed)
• Contraindications for Bamlanivimab (0 listed)
• Trade names of Bamlanivimab (3 listed)
• Bebtelovimab
• Mechanism of Action
• Typical Adult Dosage
• Typical Pediatric Dosage
• Subsequent booster
• Toxic Effects for Bebtelovimab (5 listed)
• Contraindications for Bebtelovimab (0 listed)
• Trade names of Bebtelovimab (1 listed)
• Casirivimab / Imdevimab
• Mechanism of Action
• Typical Adult Dosage
• Typical Pediatric Dosage
• Subsequent booster
• Toxic Effects for Casirivimab / Imdevimab (6 listed)
• Contraindications for Casirivimab / Imdevimab (1 listed)
• Trade names of Casirivimab / Imdevimab (2 listed).
• COVID-19 - inactivated vaccine
• Mechanism of Action
• Typical Adult Dosage
• Typical Pediatric Dosage
• Subsequent booster
• Toxic Effects for COVID-19 - inactivated vaccine (13 listed)
• Contraindications for COVID-19 - inactivated vaccine (2 listed)
• Trade names of COVID-19 - inactivated vaccine (9 listed)
• COVID-19 - mRNA vaccine
• Mechanism of Action
• Typical Adult Dosage
• Typical Pediatric Dosage
• Subsequent booster
• Toxic Effects for COVID-19 - mRNA vaccine (16 listed)
• Contraindications for COVID-19 - mRNA vaccine (2 listed)
• Trade names of COVID-19 - mRNA vaccine (8 listed)
• COVID-19 - recombinant nanoparticle vaccine
• Mechanism of Action
• Typical Adult Dosage
• Typical Pediatric Dosage
• Subsequent booster
• Toxic Effects for COVID-19 - recombinant nanoparticle vaccine (7 listed)
• Contraindications for COVID-19 - recombinant nanoparticle vaccine (3 listed)
• Trade names of COVID-19 - recombinant nanoparticle vaccine (10 listed)
• COVID-19 - viral vector vaccine
• Mechanism of Action
• Typical Adult Dosage
• Typical Pediatric Dosage
• Subsequent booster
• Toxic Effects for COVID-19 - viral vector vaccine (11 listed)
• Contraindications for COVID-19 - viral vector vaccine (2 listed)
• Trade names of COVID-19 - viral vector vaccine (14 listed)
• Regdanvimab
• Mechanism of Action
• Typical Adult Dosage
• Typical Pediatric Dosage
• Subsequent booster
• Toxic Effects for Regdanvimab (2 listed)
• Contraindications for Regdanvimab (0 listed)
• Trade names of Regdanvimab (2 listed)
• Sotrovimab
• Mechanism of Action
• Typical Adult Dosage
• Typical Pediatric Dosage
• Subsequent booster
• Toxic Effects for Sotrovimab (3 listed)
• Contraindications for Sotrovimab (1 listed)
• Trade names of Sotrovimab (0 listed)
• Tixagevimab / Cilgavimab
• Mechanism of Action
• Typical Adult Dosage.
• Typical Pediatric Dosage.